Andrew J. Stott

426 total citations
7 papers, 169 citations indexed

About

Andrew J. Stott is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Andrew J. Stott has authored 7 papers receiving a total of 169 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Organic Chemistry. Recurrent topics in Andrew J. Stott's work include Synthetic Organic Chemistry Methods (3 papers), Peptidase Inhibition and Analysis (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). Andrew J. Stott is often cited by papers focused on Synthetic Organic Chemistry Methods (3 papers), Peptidase Inhibition and Analysis (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). Andrew J. Stott collaborates with scholars based in United Kingdom, United States and China. Andrew J. Stott's co-authors include Nigel R. Burns, Jayne L. Brookman, Keith Gull, Alan J. Kingsman, Sally E. Adams, Omar Aziz, Marieke Lamers, Roland W. Bürli, Dawn Yates and Kim L. Matthews and has published in prestigious journals such as Virology, Organic Letters and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Andrew J. Stott

7 papers receiving 167 citations

Peers

Andrew J. Stott

MB

PS

ONCOL

OC

ECOLO

Matthew G. Pence United States

Zhongren Wu United States

Bryan J. Wilkins United States

Akinchan Kumar India

T. KURIHARA Japan

C. Denise Appel United States

Robert Dutnall United States

John Hintze Denmark

Yann‐Vaï Le Bihan United Kingdom

Michelle Sabourin United States

Matthew G. Pence United States

Andrew J. Stott

313 ×2.4

MB

18 ×0.5

PS

26 ×0.7

ONCOL

11 ×0.4

OC

5 ×0.4

ECOLO

Citations per year, relative to Andrew J. Stott Andrew J. Stott (= 1×) peers Matthew G. Pence

Countries citing papers authored by Andrew J. Stott

Since Specialization

Citations

This map shows the geographic impact of Andrew J. Stott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew J. Stott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew J. Stott more than expected).

Fields of papers citing papers by Andrew J. Stott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew J. Stott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew J. Stott. The network helps show where Andrew J. Stott may publish in the future.

Co-authorship network of co-authors of Andrew J. Stott

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew J. Stott. A scholar is included among the top collaborators of Andrew J. Stott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew J. Stott. Andrew J. Stott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Bürli, Roland W., Kevin Doyle, Louise Dickson, et al.. (2024). Discovery of CVN293, a Brain Permeable KCNK13 (THIK-1) Inhibitor Suitable for Clinical Assessment. ACS Medicinal Chemistry Letters. 15(5). 646–652. 2 indexed citations

2.

Hann, Elizabeth, et al.. (2022). The importance of plasma protein and tissue binding in a drug discovery program to successfully deliver a preclinical candidate. Progress in medicinal chemistry. 61. 163–214. 14 indexed citations

3.

Luckhurst, Christopher A., Omar Aziz, Vahri Beaumont, et al.. (2018). Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class IIa histone deacetylase inhibitor. Bioorganic & Medicinal Chemistry Letters. 29(1). 83–88. 38 indexed citations

4.

Penrose, Stephen D., Andrew J. Stott, Perla Breccia, et al.. (2015). Inter- and Intramolecular Annulation Strategies to a Cyclopentanone Building Block Containing an All-Carbon Quaternary Stereogenic Center. Organic Letters. 17(6). 1401–1404. 4 indexed citations

5.

Luckhurst, Christopher A., Perla Breccia, Andrew J. Stott, et al.. (2015). Potent, Selective, and CNS-Penetrant Tetrasubstituted Cyclopropane Class IIa Histone Deacetylase (HDAC) Inhibitors. ACS Medicinal Chemistry Letters. 7(1). 34–39. 42 indexed citations

6.

Brookman, Jayne L., et al.. (1995). Analysis of TYA Protein Regions Necessary for Formation of the Ty1 Virus-like Particle Structure. Virology. 212(1). 69–76. 29 indexed citations

7.

Brookman, Jayne L., Andrew J. Stott, Nigel R. Burns, et al.. (1995). An Immunological Analysis of Ty1 Virus-like Particle Structure. Virology. 207(1). 59–67. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact